Ads
related to: Januvia- How RYBELSUS® Works
Learn More About How RYBELSUS®
Works At The Patient Website.
- Considering RYBELSUS®
Visit The Official Patient Site
For More Information.
- Sign Up For Savings
Eligible Patients May Save On
Their RYBELSUS® Prescriptions.
- What To Expect
Visit The Patient Site To Learn
More About RYBELSUS®.
- Prescribing Information
View Prescribing Information For
A Potential Treatment Option.
- FAQs
Explore Frequently Asked Questions
& Learn More Today!
- How RYBELSUS® Works
Search results
Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales
CNBC· 11 hours agoMerck on Thursday reported first-quarter revenue and adjusted earnings that topped expectations as...
Merck Stock Jumps After Dow Jones Stalwart Rides Its Cancer 'Star' To Another Quarterly Beat
Investor's Business Daily· 2 hours agoSales of human papillomavirus vaccine Gardasil jumped 14% to $2.25 billion. That narrowly topped...
Merck Stock Gains On Its Blockbuster Cancer Drug Keytruda, Raises Annual Outlook
Benzinga via Yahoo Finance· 3 hours agoOn Thursday, U.S. drug maker Merck & Co Inc (NYSE:MRK) reported first-quarter sales of $15.8...
Merck (MRK) Q1 Earnings Top, Cancer Drug Keytruda Boosts Sales
Zacks via Yahoo Finance· 6 hours agoIn Diabetes, Januvia/Janumet (diabetes) franchise sales declined 21% year over year to $670 million....
20 Fastest Growing Health Tech Companies in the World
Insider Monkey via Yahoo Finance· 6 hours agoIn this article, we will be taking a look at the 20 fastest growing health tech companies in the...
Merck’s first-quarter results beat expectations amid healthy vaccine-sales growth
Market Watch· 11 hours agoMerck & Co. Inc. on Thursday reported first-quarter results that beat analysts’ expectations amid...
Will Higher Keytruda Sales Drive Merck's Q1
Forbes· 2 days agoMerck (NYSE: MRK) will report its Q1 2024 results on Thursday, April 25. As usual, Keytruda will be the driving growth for Merck with quarterly sales...
How Many More Ozempic-like Drugs Are In the Pipeline — Here’s What Researchers Are Working On
Inverse· 5 days agoFew drugs have achieved the stardom that semaglutide, marketed in the United States as Ozempic or...
Merck & Co., Inc. (NYSE:MRK) Earns Overweight Rating from Cantor Fitzgerald
ETF DAILY NEWS· 5 days agoCantor Fitzgerald reiterated their overweight rating on shares of Merck & Co., Inc. (NYSE:MRK – Free Report) in a report published on Thursday morning, Benzinga reports. They currently have ...
Q3 2024 Earnings Forecast for Merck & Co., Inc. Issued By Leerink Partnrs (NYSE:MRK)
ETF DAILY NEWS· 4 days agoMerck & Co., Inc. (NYSE:MRK – Free Report) – Research analysts at Leerink Partnrs raised their Q3 2024 earnings per share estimates for Merck & Co., Inc. in a report released on Friday, April ...
Ads
related to: Januvia
